Science Advances · 2019 · 105 citations · 32 references
MedicineOncologyPharmacologyCancer ImmunologyMolecular OncologySignal TransductionAntitumor T Cell ResponsesCancer ImmunotherapyCheckpoint Inhibitor TherapyImmune Checkpoint InhibitorsImmune Checkpoint ModulationImmune Checkpoint RegulationAnimal Disease ModelsApc InactivationCanonical Wnt PathwayInhibitory Checkpoint RegulationPd-1 SignalingSelective Cancer TherapyTumor Microenvironment EffectsTumor-targeting Peptides
mutation in colorectal cancers, it indicates our peptides can reactivate anti-cancer immune response suppressed by the oncogenic Wnt pathway. In summary, we report a promising strategy for cancer therapy by pharmacological inhibition of the Wnt/β-cat signaling.
32
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Stefani Spranger, Riyue Bao, Thomas F. Gajewski · Nature · 2015 · 2.8K citations
Medicine, Cancer Biology, Oncology +10
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li, Eric A. Severson, Jean‐Christophe Pignon et al. · Genome biology · 2016 · 2.8K citations · Full text
Life Sciences, Immunology, Oncology +17
Bruce J. Giantonio, Paul J. Catalano, Neal J. Meropol et al. · Journal of Clinical Oncology · 2007 · 2.3K citations
Medicine, Oncology, Pharmacotherapy +15